Regeneca, Inc. Issues a Voluntary Nationwide Recall of a Specific Lot of RegenArouse Because of Potential Health Risks

IRVINE, Calif., Feb. 11, 2012 (GLOBE NEWSWIRE) -- Regeneca, Inc. (Pink Sheets:RGNA) announced today that it is conducting a voluntary nationwide recall of RegenArouse, Lot Number 130100, because FDA lab analysis has confirmed the presence of Tadalafil making these products unapproved new drugs. Tadalafil is an FDA-approved drug used as treatment for male Erectile Dysfunction (ED). The active drug ingredient is not listed on the label for these products. Use of these products may pose a threat to co...continued RGNA

URL: http://www.investorpoint.com/news/INTHPINK/48342871/